Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma.
Saved in:
| Title: | Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma. |
|---|---|
| Authors: | van Meerten T; Department of Haematology, University Medical Center Groningen Groningen, The Netherlands., Kuruvilla J; Princess Margaret Cancer Centre Toronto, ON, Canada., Song KW; Vancouver General Hospital, BC Cancer, The University of British Columbia Vancouver, BC, Canada., Thieblemont C; Assistance Publique-Hôpitaux de Paris, Hemato-Oncology, Hôpital Saint-Louis, Paris University Paris, France., Minnema MC; Department of Haematology, University Medical Center Utrecht Utrecht, The Netherlands., Forcade E; CHU Bordeaux, Service d'Hematologie et Thérapie Cellulaire Bordeaux, France., De Guibert S; Hématologie Clinique, CHU Rennes Rennes, France., Kersten MJ; Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam Amsterdam, The Netherlands., Mutsaers PG; Department of Hematology, Erasmus University Medical Center Rotterdam, The Netherlands., Wermke M; TU Dresden Medizinische Fakultät Carl-Gustav Carus, NCT/UCC Early Clinical Trial Unit/Medizinische Klinik I Dresden, Germany., Zheng Y; Kite, a Gilead Company Santa Monica, CA, USA., Xue A; Kite, a Gilead Company Santa Monica, CA, USA., Winters JN; Kite, a Gilead Company Santa Monica, CA, USA., Nater J; Kite, a Gilead Company Santa Monica, CA, USA., Shen RR; Kite, a Gilead Company Santa Monica, CA, USA., Spooner C; Kite, a Gilead Company Santa Monica, CA, USA., Neumann F; Kite, a Gilead Company Santa Monica, CA, USA., Kim JJ; Kite, a Gilead Company Santa Monica, CA, USA., Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg Würzburg, Germany. |
| Source: | American journal of cancer research [Am J Cancer Res] 2024 Jun 15; Vol. 14 (6), pp. 2905-2920. Date of Electronic Publication: 2024 Jun 15 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101549944 Publication Model: eCollection Cited Medium: Print ISSN: 2156-6976 (Print) Linking ISSN: 21566976 NLM ISO Abbreviation: Am J Cancer Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
